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Summary
A carotenoid desaturase homolog from Staphylococ-
cus aureus (CrtOx) was identified. When expressed in
engineered E. coli cells synthesizing linear C30 carot-
enoids, polar carotenoid products were generated,
identified as aldehyde and carboxylic acid C30 carot-
enoid derivatives. The major product in this engi-
neered pathway is the fully desaturated C30 dialde-
hyde carotenoid 4,4-diapolycopen-4,4-dial. Very low
carotenoid yields were observed when CrtOx was
complemented with the C40 carotenoid lycopene path-
way. But extension of an in vitro evolved pathway of
the fully desaturated 2,4,2,4-tetradehydrolycopene
produced the structurally novel fully desaturated C40
dialdehyde carotenoid 2,4,2,4-tetradehydrolycopen-
dial. Directed evolution of CrtOx by error-prone PCR
resulted in a number of variants with higher activity
on C40 carotenoid substrates and improved product
profiles. These findings may provide new biosyn-
thetic routes to highly polar carotenoids with unique
spectral properties desirable for a number of indus-
trial and pharmaceutical applications.
Introduction
Carotenoids are a structurally diverse group of pig-
mented biomolecules of emerging importance as food
supplements or colorants and in nutraceutical and
pharmaceutical applications. Carotenoids are structur-
ally classified based on the number of backbone car-
bon molecules, usually C30, C40, or C50. Carotenoid bio-
synthesis occurs via a head-to-head condensation
reaction of isoprenoid precursors followed by a desat-
uration reaction to increase the number of conjugated
double bonds generating the distinctive carotenoid
chromophore. Generally well-conserved carotenoid syn-
thase and desaturase enzymes catalyze these reac-
tions [1].
Further modification reactions, catalyzed by a di-
verse array of modifying enzymes, generate the con-
siderable structural diversity observed in natural carot-
enoids. C30 carotenoids are relatively uncommon linear
molecules found primarily in Gram-positive microorga-
nisms such as Staphylococcus aureus strains [2],
Methylobacterium rhodinum (formerly Pseudomonas
rhodos) [3], and Heliobacteria [4]. The C30 carotenoids
described from these organisms are often modified at*Correspondence: schmi232@tc.umn.eduone or both ends by glycosylation or acylation, and
synthesis is thought to occur via an oxygenated in-
termediate [5, 6]. Although the genes responsible for
C30 carotenoid backbone synthesis are known (dehy-
drosqualene synthase crtM and dehydrosqualene de-
saturase crtN) [7], the modifying genes from these or-
ganisms have not been characterized.
The major carotenoid of the pathogen Staphylococ-
cus aureus is staphyloxanthin (Figure 1, structure 13).
Structural studies have indicated that it is a derivative
of the C30 carotenoid diaponeurosporene modified by
glycosylation and acylation at one terminal methyl
group. Mutagenesis and color screening of S. aureus
indicated that the biosynthesis proceeds by the intro-
duction of terminal oxygen functions to form a carbox-
ylic acid via an aldehyde intermediate. This is followed
by the esterification of glucose to this carboxyl ter-
minus and esterification of a fatty acid to the glucose
moiety [5]. Similar studies on the bacterium Methylo-
bacterium rhodinum suggested that diapolycopene de-
rivatives observed in this organism with one or both
termini modified by glycosylation and acylation were
synthesized via similar intermediates [6].
The biosynthesis of short-chain, polar carotenoid
molecules has considerable potential in industrial and
biomedical applications. The recently reported plant
biosynthetic pathways for crocetin [8] and bixin [9] pro-
ceed via enzymatic cleavage of C40 carotenoid sub-
strates to produce oxygenated short-chain apo-carot-
enoids that are further modified by methylation or
glycosylation. The products of these reactions are often
water soluble and are important natural food additives
with potential as cancer therapeutic agents [10].
By DNA shuffling of carotenoid desaturases (CrtI)
from Erwinia species, a variant enzyme (CrtI14) was pre-
viously reported that catalyzes the extended desatura-
tion of the linear C40 carotenoid pathway to 3,4,3#4#-
tetradehydrolycopene and when combined with an
evolved carotenoid cyclase, produces the monocyclic
carotenoid torulene [11]. This pathway was extended
by combinatorial engineering with a number of carot-
enoid modifying enzymes, to produce an array of struc-
turally novel products [12]. In this paper we extend this
methodology to new carotenoid products by engineer-
ing and directed evolution of a S. aureus C30 carotenoid
oxygenase for the production of oxygenated, linear C30
and C40 carotenoids in E. coli.
Results
Identification and Cloning of S. aureus C30
Carotenoid Biosynthetic Genes
NCBI BLAST homology searches [13] using the known
S. aureus diapophytoene synthase (CrtN) amino acid
sequence (GenBank accession number B55548) re-
vealed a homologous open reading frame upstream of
CrtN within the genomic DNA sequences of S. aureus
strains. Analysis of this region by the TIGR CMR data-
base [14] suggested that the known S. aureus carot-
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454Figure 1. Biosynthesis of Oxygenated C30 and C40 Carotenoids
Biosynthetic pathways to oxygenated, linear C30 (A) and C40 (B) carotenoids. Solid arrows represent natural biosynthetic pathways suggested
for staphyloxanthin in S. aureus (A) and lycopene (B). Biosynthetic pathway steps in engineered recombinant E. coli are indicated by dashed
arrows. Carotenoids identified in recombinant E. coli are underlined.enoid biosynthetic genes were preceded by three addi- (
jtional genes in a typical bacterial operon structure
(Figure 2). These consisted sequentially of a small ORF c
owith no known functional homology (GenBank acces-
sion number NP_373089), a homolog of crtN (GenBank (
caccession number NP_373088, 25% identity, 48% sim-
ilarity), an ORF with a conserved glycosyl transferase e
smotif (GenBank accession number NP_373087), fol-
lowed by the known genes crtN and dehydrosqualene t
tsynthase crtM (GenBank accession number A55548).
The structure of this operon suggested these genes J
omay be involved in the biosynthesis of staphyloxanthinFigure 1, structure 13), the glycosylated, acylated ma-
or carotenoid of S. aureus [2]. In order to functionally
haracterize these genes, they were subcloned into the
verexpression vector pUCMod for expression in E. coli
see Table 1 for plasmid and gene names). However,
loning of the genes NP_373089 and NP_373087 proved
xtremely difficult, and although clones with correct
equences were obtained, the E. coli strains harboring
hese plasmids grew extremely slowly with an unusual,
ransparent colony morphology on agar plates. E. coli
M109 harboring pUCMod-NP_373088 did not dem-
nstrate this growth inhibition. When pUCMod-
Biosynthesis of Oxygenated Carotenoids
455Figure 2. S. aureus Carotenoid Operon
Region of the S. aureus genome sequence showing open reading
frames upstream of the known S. aureus carotenoid genes crtM
(dehydrosqualene synthase) and crtN (dehydrosqualene desatu-
rase) in a typical bacterial operon structure. NP_373089, crtOX;
NP_373089, no known functional homology; NP_373087, con-
served glycosyl transferase motif.4A). These were analyzed by mass spectrometry and rapidly with NaBH4, producing a more polar, yellow-
Table 1. Genes and Plasmids Used in This Study
Accession
Number or
Gene Enzyme Typical Reaction Catalyzed Reference
ispA FDP synthase Head-to-head condensation of 2 IDP + 1 DMADP AB025791
crtM Dehydrosqualene synthase Head-to-head condensation of 2 FDP X73889
crtN Diapophytoene synthase Introduction of three desaturations in dehydrosqualene X73889
crtE GGDP synthase Head-to-head condensation of IDP + FDP D90087
crtB Phytoene synthase Head-to-head condensation of 2 GGDP D90087
crtI Phytoene desaturase Introduction of four desaturations in phytoene D90087
crtI14 In vitro evolved phytoene desaturase Introduction of six desaturations in phytoene [11]
crtOx Diapocarotenal synthase Oxygenation of acyclic carotenoid end groups This study
Plasmid Properties Reference
pUCMod Cloning vector, high copy-number, constitutive lac promoter, [11]
AmpR
pACMod Cloning vector, low copy-number, constitutive lac promoter, CmR [11]
pAC-ispA-crtM-crtN Constitutively expressed E. coli IspA, S. aureus CrtN, and S. [12]
aureus CrtM producing diapolycopene
pAC-crtE-crtB-crtI Constitutively expressed E. uredovora CrtE, CrtB, and CrtI [11]
producing lycopene
pAC-crtE-crtB-crtI14 Constitutively expressed E. uredovora CrtE, CrtB, and in vitro- [11]
evolved desaturase CrtI14 producing tetradehydrolycopene
pUC-crtOx Constitutively expressed S. aureus diapocarotenal synthase This study
CrtOx
Constitutively expressed S. aureus diapocarotenal synthase
pUC-crtOxmut1-3 CrtOxmut1-3 obtained by error-prone PCR mutagenesis This studyNP_373088 was electrotransformed into strain JM109
harboring the plasmid pAC-ispA-crtM-crtN (producing
the C30 carotenoid diapolycopene) [11], cells with a
deep red phenotype were produced (Figure 3A), indi-
cating a change in carotenoid production when com-
pared to the yellow-orange cells of the background
strain.
Characterization of C30 Carotenoids
For analysis of carotenoids, E. coli strain JM109 har-
boring pAC-ispA-crtM-crtN and pUC-NP_373088 was
cultured in LB medium supplemented with glycerol at
30°C, as previous results have indicated that low tem-
peratures and glycerol supplementation enhance carot-
enoid production [15]. Initial analysis of carotenoid ex-
tracts by TLC (Figure 3) indicated that a number of
carotenoids were present compared to a control strain
JM109 harboring pAC-ispA-crtM-crtN and pUCMod
vector without insert DNA. HPLC analysis indicated the
presence of a number of additional polar peaks (FigureFigure 3. Carotenoid Production in Recombinant E. coli Cells
LB media cultures (top), cell pellets (center), and TLC analysis (bot-
tom) of recombinant C30 (A) and C40 (B) carotenoid-producing
E. coli strains. Background plasmids strains are JM109 pAC-ispA-
crtM-crtN (A) and pAC-crtE-crtB-crtI14 (B) cotransformed with 1.
pUCMod, 2. pUC-crtOx, 3. pUC-crtOxmut1, 4. pUC-crtOxmut2, and 5.
pUC-crtOxmut3. Identified compounds from Figure 1 are indicated.by a combination of HPLC retention times, UV-Vis fine
spectra, and Mass-spectra the major peaks were as-
signed structures in Figure 1. The properties of the ca-
rotenoids are summarized in Table 2. The major product
is a violet compound with a [M]+ of m/z 429.0 assigned
as 4,4#-diapolycopen-4,4#-dial. Characteristic mass frag-
ments of two aldehyde functions were observed (M-18,
M-28, M-18-18, M-18-28) as well as characteristic ca-
rotenoid extrusion losses of toluene (M-92) and xylene
(M-106). The major violet carotenoid reacted very
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Figure 4. Analysis of E. coli Cells Producing Oxygenated C30 Carot- t
enoids O
HPLC profiles of recombinant E. coli expressing the C30 carotenoid p
background plasmid pAC-ispA-crtN-crtM with (A) pUC-crtOx, (B)
opUC-crtOxmut1, (C) pUC-crtOxmut2, (D) pUC-crtOxmut3, and E. coli
Texpressing the C40 carotenoid background plasmid pAC-crtE-crtB-
scrtI14 with (E) pUC-crtOx, (F) pUC-crtOxmut1, (G) pUC-crtOxmut2, and
(H) pUC-crtOxmut3. n
t
t
dorange compound by TLC analysis as a result of the re-
duction of terminal aldehyde groups to hydroxyl groups
(data not shown). A less polar peak with a [M]+ of m/z C
o417.1 consistent with a mono-aldehyde derivative of di-
aponeurosporene (Figure 4A, peak 9) was also ob- T
Wserved with mass fragments characteristic of a single
aldehyde group (M-18, M-28). Reaction with NaBH4 c
trapidly generated a more polar, yellow product by TLC
with an Rf consistent with a carotenoid monoalcohol. lhese results indicate the enzyme encoded by ORF
P_373088 catalyzes the addition of one or more alde-
yde groups to C30 carotenoid terminal methyl groups
nd is likely responsible for the synthesis of the mono-
ldehyde intermediate observed in the biosynthesis of
taphyloxanthin [5]. As a result we have designated this
xygenase gene CrtOx, diapocarotenal synthase.
In addition to the major product 4,4#-diapolycopen-
,4#-dial, two more polar peaks were observed by
PLC analysis, suggesting products with additional
xygen functions are present. Although present in rela-
ively low yields, parent masses could be obtained for
oth compounds and structures putatively assigned.
he least polar of these (Figure 4A, peak 10) has a par-
nt mass [M]+ of m/z 433.1 and characteristic frag-
ents of M-2, and M-18, and was assigned as hydroxy-
,4#-diaponeurosporenal. Reaction with NaBH4 was
apid and produced a more polar, yellow product by
LC, indicating reduction to a carotenoid dialcohol. The
ack of UV-Vis fine structure observed for this com-
ound (Table 2) suggests the aldehyde function is lo-
ated adjacent to the conjugated double bond system,
nd this compound could therefore be assigned as 4#-
ydroxyl-4,4#-diaponeurosporen-4-al (Figure 1, com-
ound 10). The most polar peak (Figure 4A, peak 7) with
[M]+ of m/z 445.0 and a very strong fragment at M-18
nd an additional fragment at M-36 was assigned as
,4#-diapolycopen-4-al-4#-oic acid. Although present in
elatively low yields, the presence of this compound
uggests that CrtOx catalyses both the oxidation of C30
arotenoids to aldehydes and the further oxidation of
hese aldehyde groups to carboxylic acids. The ex-
ected final product of this engineered pathway, 4,4#-
iapolycopen-4,4#-dioic acid was not observed in ace-
one extracts and increasing culture times of 48, 64,
nd 96 hr yielded only similar product profiles by HPLC
nalysis (data not shown). However, cell pellets of these
ultures after acetone extraction demonstrated that
evels of a red pigment not accessible by acetone ex-
raction increased over time. This pigment could not by
xtracted with a range of organic solvents but could be
olubilized by the addition of 1% aqueous KOH to cell
ellets followed by stirring at room temperature for 2
r. This is consistent with the chemical properties of
he plant C24 dicarboxylic acid carotenoid norbixin [9]
hat forms a soluble potassium salt in aqueous KOH.
n the addition of acetic acid to pH 5, an insoluble
recipitate formed that was not soluble in a number of
rganic solvents tested with the exception of DMSO.
he lack of solubility of this compound in most organic
olvents renders purification and analysis difficult and
o clear analytical data could be obtained. However,
he known biochemical pathway and physical proper-
ies of the pigment strongly suggest a diapocarotene-
ioic acid.
40 Carotenoids Produced by Complementation
f CrtOx with the In Vitro-Evolved
etradehydrolycopene Pathway
hen E. coli JM109 harboring the plasmid pAC-crtE-
rtB-crtI necessary for C40 carotenoid lycopene syn-
hesis was electrotransformed with pUC-crtOx, very
ow levels of more polar carotenoids were observed by
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457Table 2. Properties of Carotenoids
UV-Vis Maxima
Structure Exact Observed [Shoulder] (in
(Figure 1) Compound Mass [M]+ (m/z) Observed Fragments Acetonitrile)
6 Diapolycopenedial 428.27 429.0 M-18, M-28, M-36, M-46, M-92, 508 [536]
M-106
7 Diapolycopen-al-oic acid 444.27 445.0 M-18, M-36, M-110 515 [539]
9 Diaponeurosporenal 416.31 417.1 M-18, M-28, M-92, M-106 469 [490]
10 Hydroxy-Diaponeurosporenal 432.3 433.1 M-2, M-18, M-28, M-36, M-92, 480 [500]
M-106
19 Tetradehydrolycopenal 546.39 547.2 M-18, M-92, M-106 521 [552]
20 Tetradehydrolycopendial 560.37 561.1 M-18, M-28, M-36, M-92, M-106 537 [563]
21 Didehydrolycopenal 548.4 549.2 M-18, M-28, M-92, M-106 513 [541]TLC when compared to a control strain transformed
with pUCMod. HPLC analysis of carotenoid extracts of
E. coli strain JM109 harboring pAC-crtE-crtB-crtI with
pUCMod or pUC-crtOx (Figure 5) indicated that the
presence of CrtOx significantly reduced the yield of ly-
copene and increased the accumulation of the precur-
sor molecule phytoene. Although very low levels of more
polar products were observed, these results indicate that
lycopene is a poor substrate for CrtOx and that an en-
zyme interaction may be disrupting desaturation by
CrtI. We previously described the complementation ofFigure 5. Carotenoid Profiles of Lycopene-Producing Recombinant
E. coli Cells with and without CrtOx Present
HPLC profiles at wavelengths of 300 and 500 nm of recombinant
E. coli expressing the C40 carotenoid lycopene background plas-
mid pAC-crtE-crtB-crtI with (A) pUCMod and (B) pUC-crtOx. Based
on mass spectrometry, HPLC retention time, and UV-Vis spectra,
the peaks were identified as L: lycopene (500 nm) and P: phytoene
(300 nm).the in vitro-evolved C40 carotenoid 2,4,2#,4#-tetradehy-
drolycopene pathway with a number of carotenoid modi-
fying enzymes in recombinant E. coli [12]. When E. coli
JM109 harboring the plasmid pAC-crtE-crtB-crtI14 nec-
essary for tetradehydrolycopene synthesis was electro-
transformed with pUC-crtOx, cells with a deep red color
phenotype were produced when compared to the pink/
red color of the background strain with pUCMod vector
without insert. HPLC analysis (Figure 4E) indicated that
a number of new polar products were present. In order
to structurally characterize these carotenoids they were
analyzed by HPLC-mass spectrometry. The assigned
structures of the major peaks on the HPLC chromato-
gram shown in Figure 1 were determined by a combina-
tion of HPLC retention times, UV-Vis spectra, and Mass
spectra summarized in Table 2. The major product (Fig-
ure 4E, peak 20), with a parent mass [M]+ of m/z 561.1
and mass fragments characteristic of two aldehyde
functions (M-18, M-28, M-18-18) and characteristic ca-
rotenoid extrusion losses of toluene (M-92) and xylene
(M-106) was identified as the fully desaturated C40 dial-
dehyde 2,4,2#,4#-tetradehydrolycopendial. However, con-
siderable levels of the C40 biosynthesis pathway precur-
sor lycopene were also observed (Figure 4E, peak 16).
This suggests that although CrtOx is active on more
desaturated C40 carotenoid substrates, it has little ac-
tivity on pathway precursors such as lycopene. Two ad-
ditional less polar molecules could be identified as
mono-aldehyde derivatives. The least polar of these
(Figure 4E, peak 21) with a [M]+ of m/z 549.2 was as-
signed as 2,4-didehydrolycopenal and the higher yield,
more polar peak (Figure 4E, peak 19) with a [M]+ of
m/z 547.2 was assigned as 2,4,2#,4#-tetradehydrolyco-
penal. Both had the characteristic mass fragments of
one aldehyde function (M-18, M-28) and characteristic
carotenoid extrusion losses of toluene (M-92) and xy-
lene (M-106). No peaks corresponding to aldehyde de-
rivatives of lycopene were present. Although additional
highly polar compounds can be observed in the HPLC
chromatogram, these were relatively low yield and mo-
lecular structures could not be positively identified by
mass spectrometry. These may represent low yields of
mono- or dicarboxylic acids or nonspecific pathway
derivatives.
Construction of In Vitro Evolution Libraries
and Isolation and Sequence of Mutants
In order to alter the product profile of the C40 carot-
enoids produced by complementation with CrtOx and
Chemistry & Biology
458improve the relative yields of oxygenated C40 carot- 4
lenoids, an error-prone PCR mutagenesis library of
CrtOx was constructed and electrotransformed into u
mE. coli strain JM109 harboring the plasmid pAC-
crtE-crtB-crtI14 necessary for 2,4,2#,4#-tetradehydroly- c
ccopene production. Colonies with altered carotenoid
production were identified by color screening. Screen-
ing of approximately 3000 colonies by this method D
yielded three mutants with altered cell pigment pheno-
types designated CrtOxMut1, CrtOxMut2, and CrtOxMut3. T
These colonies had deep purple (CrtOxMut1, CrtOxMut2) f
and blue/gray (CrtOxMut3) color phenotypes (Figure 3B). l
The DNA sequences of the inserts of these plasmids b
were determined and plasmids retransformed into B
E. coli cells harboring pAC-crtE-crtB-crtI14, confirming t
the color phenotypes observed. The mutants were also s
electrotransformed into E. coli JM109 harboring pAC- s
ispA-crtN-crtM to test the activity of these mutants i
against C30 carotenoid substrates (Figure 3A). The t
amino acid changes in the CrtOx sequence for each w
mutant were as follows: CrtOxMut1–V355A, Q483L; a
CrtOxMut2–V355A; CrtOxMut3–Y62H, Y189C, K393E. T
l
bCarotenoid Analysis of In Vitro-Evolved CrtOx
Mutants Complemented with C30 and C40 Pathways t
HPLC chromatograms of the carotenoid products of
the in vitro-evolved CrtOx genes coexpressed with the n
srecombinant 2,4,2#,4#-tetradehydrolycopene pathway
are shown in Figures 4F–4H. Based on HPLC reten- c
rtion times and UV-Vis spectra, it appeared that the
mutant enzymes produced no significant amounts of i
inew products. However, considerable alterations in the
product profiles were detected, consistent with the al- C
ptered color phenotypes observed by screening (Figure
3B). CrtOxMut1 and CrtOxMut2, as expected from the p
osimilar amino acid sequence and colony color pheno-
type of these mutants, have similar overall product pro- d
pfiles. Both have higher yields of 2,4,2#,4#-tetradehydro-
lycopendial (CrtOxMut1: 57% increase, CrtOxMut2: 18% p
sincrease) and lower yields of the more polar, uniden-
tified products. In addition, a significant decrease in the j
orelative yield of the precursor lycopene was also ob-
served. This is likely to be partly responsible for the t
aaltered color phenotypes observed by screening. By
peak integration of spectra at 500 nm, wild-type CrtOx p
aproduces a ratio of 2.6:1 (2,4,2#,4#-tetradehydrolyco-
pendial:lycopene) whereas CrtOxMut1 has a ratio of e
f4.8:1 and CrtOxMut2 6.4:1. Finally, CrtOxMut3 shows the
most dramatic change in product spectrum accordant f
awith the greater number of amino acid changes ob-
served. Although it has the lowest yield of 2,4,2#,4;- e
mtetradehydrolycopendial (41% decrease compared to
CrtOx wild-type), the precursor compound lycopene is m
almost completely absent compared to 2,4,2#,4;-tetra-
dehydrolycopendial with a ratio of 21:1 and significant S
cpeaks of the more polar, unidentified compounds ob-
served are not present. By integration of all carotenoid m
ipeaks observed at 500 nm, 2,4,2#,4#;-tetradehydrolyco-
pendial represents 84.5% of the total carotenoids de- 3
btected in this strain.
In contrast, the in vitro evolved CrtOx enzymes ap- g
Epeared to have a less dramatic effect on the product
profiles of the C diapolycopene pathway (Figures 4B– m30D). However, a considerable decrease in the accumu-
ation of the more polar products can be observed (Fig-
res 4B–4D, peaks 7 and 10). This suggests that the
utations may have some influence on the putative
arboxylic acid synthesis function of the enzyme on C30
arotenoid substrates.
iscussion
he C30 carotenoid biosynthesis genes crtM and crtN
rom S. aureus have previously been reported to cata-
yze the synthesis of linear C30 carotenoid backbones
ut not the major S. aureus carotenoid staphyloxanthin.
y analysis of the region surrounding these genes in
he S. aureus genome, we identified an operon-like
tructure that may be involved in staphyloxanthin bio-
ynthesis. Heterologous expression of the gene crtOx
n E. coli, along with crtM and crtN, resulted in the syn-
hesis of oxygenated C30 carotenoids. A minor peak
ith a parent mass consistent with mono-carboxylic
cid/mono-aldehyde derivative was also observed.
his strongly suggests that the single gene crtOx cata-
yzes the biosynthesis of both the aldehyde and car-
oxylic acid intermediates in staphyloxanthin biosyn-
hesis.
Interestingly, the major product observed in recombi-
ant E. coli was a dialdehyde derivative of the fully de-
aturated C30 carotenoid diapolycopene, which is in
ontrast to staphyloxanthin, a diaponeurosporene de-
ivative oxygenated at only one terminus. This product
s likely the result of the engineered E. coli pathway
n which all enzymes are constitutively expressed and
rtOx is expressed on the high copy-number plasmid
UCMod and the remaining genes on low copy-number
ACMod. This may increase the pathway flux to more
xygenated products and thus a dialdehyde carotenoid
erivative is formed. The fully desaturated (diapolyco-
ene) backbone of the final product is consistent with
reviously reported recombinant C30 carotenoid bio-
ynthesis in which diapolycopene is produced as a ma-
or product [12]. As CrtOx is homologous to CrtN and
ther carotenoid desaturases, it is possible that it re-
ains some desaturase activity but expression of CrtOx
nd CrtM, in the absence of CrtN, failed to produce
igmented carotenoids (data not shown). The amino
cid sequence relatedness of CrtN and CrtOx suggests
volution via a gene duplication event and subsequent
unctional differentiation. Although there are relatively
ew examples of carotenoid desaturase homologs with
n alternative activity, some of the many putative carot-
noid desaturases annotated in genome sequences
ay also have alternative functions and only experi-
ental characterization of these genes will clarify this.
Two additional genes were identified in the putative
. aureus carotenoid operon. ORF NP_373087 has a
onserved glycosyl transferase motif, suggesting it is
ay catalyze the addition of the sugar moiety observed
n staphyloxanthin. The remaining small ORF NP_
73089 has no significant homology to known enzymes
ut may be a structurally novel acyl-transferase. The
rowth inhibition on overexpression of these genes in
. coli indicates they have some influence on E. coli
etabolism and may be accepting alternative sub-
Biosynthesis of Oxygenated Carotenoids
459strates. Additional characterization of these enzymes in
a recombinant system to confirm activity may be pos-
sible with a more modulated expression system.
As with previous carotenoid modifying enzymes in-
vestigated [12], CrtOx was a relatively promiscuous en-
zyme, readily able to accept C40 carotenoid substrates.
Initial experiments by complementing CrtOx with the
genes necessary for synthesis of the C40 carotenoid ly-
copene (Figure 1, structure 16) resulted in a significant
reduction in carotenoid yield when compared to a con-
trol. When combined with the in vitro-evolved 2,4,2#,4#-
tetradehydrolycopene pathway, CrtOx catalyzed the
synthesis of highly desaturated mono- and di-aldehyde
C40 carotenoids. The engineered 2,4,2#,4#-tetradehydro-
lycopene pathway also accumulates significant levels of
the precursor lycopene and this was also observed with
the addition of CrtOx. This accumulation, and the lack
of observed oxygenated lycopene derivatives, indi-
cates that CrtOx preferentially accepts more desatur-
ated substrates. The lack of carotenoid production and
desaturation activity observed when CrtOx was coex-
pressed with the lycopene biosynthesis pathway may be
the result of the formation of a disrupted carotenogenic
enzyme complex. The major product of CrtOx activity on
the 2,4,2#,4#-tetradehydrolycopene biosynthesis pathway
was identified as the deep violet dialdehyde derivative
2,4,2#,4#-tetradehydrolycopendial. Although a number
of more polar peaks were observed on HPLC analysis,
they could not be positively identified. Based on the
results of the engineered C30 pathway, these may repre-
sent carboxylic acid derivatives but further character-
ization is necessary to confirm this.
Color screening of CrtOx error-prone PCR libraries
with the engineered 2,4,2#,4#-tetradehydrolycopene
pathway yielded three clones with an altered color
phenotype. Sequencing revealed each clone contained
a unique pattern of mutations although CrtOxMut1
CrtOxMut2 share an amino acid change. Although HPLC
analysis of the carotenoid profiles of the mutant strains
indicated no novel products were observed, consider-
able changes in product distribution were observed.
These changes are responsible for the altered color
phenotypes observed. All of these mutants have
relatively reduced yields of the pathway precursor
lycopene, which again suggests some interaction of
these heterologous enzymes is taking place. Mutant
CrtOxMut3 has the most significant change in product
profile and although overall yield is lower, 2,4,2#,4#-tet-
radehydrolycopendial in produced in considerable ex-
cess over other carotenoids detected. It is very difficult
to speculate on the function of the amino acid changes A
observed in the mutants as no structural data are avail-
able for the carotenoid desaturase enzyme family.
Coexpression of the CrtOx variants with the C30 carot-
enoid biosynthesis pathway yielded similar carotenoid
product profiles to the wild-type CrtOx clone. However,
a reduced accumulation of the more polar carboxylic
acid products observed in these samples, along with
the C40 pathway, suggests these mutations may com-
promise the aldehyde oxidase function of the enzyme.
This also indicates that these highly polar carotenoid
products are the result of enzymatic activity of wild-
type CrtOx and not nonspecific in vivo activity.Significance
Highly polar, linear carotenoid molecules frequently
demonstrate unique spectral properties and oxygen-
ated short-chain carotenoids may be water soluble, a
considerable advantage in many industrial and phar-
maceutical applications. By analysis of S. aureus ge-
nome sequences, we identified a carotenoid desatu-
rase homolog CrtOx. Coexpression of this gene with
the previously characterized, recombinant C30 bio-
synthetic pathway in E. coli yielded oxygenated carot-
enoids, including the major product identified as the
fully desaturated C30 di-aldehyde carotenoid 4,4-dia-
polycopen-4,4-dial. These results indicate CrtOx is
responsible for the biosynthesis of aldehyde and
carboxylic acid carotenoid intermediates observed in
S. aureus. Coexpression of CrtOx with genes neces-
sary for the synthesis of the C40 carotenoid lycopene
resulted in low carotenoid production in this strain.
However, when CrtOx was combined with a pre-
viously reported, in vitro-evolved pathway for the syn-
thesis of 2,4,2,4-tetradehydrolycopene, significant
yields of oxygenated C40 carotenoids were observed,
including the major product identified as the fully de-
saturated C40 di-aldehyde carotenoid 2,4,2,4-diapo-
lycopendial. By directed evolution, CrtOx mutants
with significantly improved production and yields of
2,4,2,4-diapolycopendial were generated. These mu-
tants are ideal candidates to develop high-yield pro-
cesses for the recombinant synthesis of this pink/vio-
let, highly polar carotenoid.
Experimental Procedures
Sequence Analysis
Whole genome DNA sequences of S. aureus strains MW2 (NC_
003923), N315 (NC_002745), and Mu50 (NC_002758) were obtained
from NCBI. Protein sequences of S. aureus CrtN (B55548) and CrtM
(A55548) were obtained from NCBI. Homology searches were per-
formed using NCBI BLAST software [13]. Genome region analysis
and ORF prediction were performed using TIGR Comprehensive
Microbial Resource [14]. Sequence editing was performed using
Bioedit software [16].
Plasmid Construction
The construction of the plasmids pAC-ispA-crtM-crtN, pAC-crtE-
crtB-crtI, and pAC-crtE-crtB-crtI14 producing diapolycopene, lyco-
pene, and 2,4,2#,4#-tetradehydrolycopene, respectively, has been
described previously [11, 12]. The C30 carotenoid oxygenase gene
crtOx (GenBank accession number NP_373088) was amplified from
S. aureus (ATCC 35556D) genomic DNA using the oligonucleotides
CrtOx-f-X (5#-GCTCTAGAAGGAGGATTACAAAATGACTAAACATAT
CATCG-3#) and CrtOx-r-N (5#-TTCCTTTGCGGCCGCTCACTTCCT
TTCTTCGC-3#) with added XbaI and NotI sites, respectively. The
forward primer CrtOx-f-X also contains an optimized Ribosome
Binding Site (underlined). This PCR product was digested with XbaI
and NotI enzymes, gel purified, and ligated into similarly prepared
pUCMod vector [11]. Insert containing plasmids were isolated and
a number sequenced to confirm no PCR errors were present. Addi-
tional S. aureus genes (GenBank accession numbers NP_373087
and NP_373089) were amplified with specific primers and cloned
in the same fashion.
For error-prone PCR mutagenesis [17], the crtOx gene in pUC-
Mod was amplified with the PCR primers (5#-CCGACTGGAAAGC
GGG-3# and 5#-ACAAGCCCGTCAGGG-3#) flanking the gene and
promoter. The PCR reaction mix consisted of 1× Promega Mg2+
free thermophilic buffer (Promega, Madison, WI), 10 ng/ml template
plasmid, 1 M of each primer, 5 U Taq DNA polymerase, and 0.3
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460mM dNTP mix. MgCl2 and MnCl2 were added to a final total salt
concentration of 2 mM and separate reactions were performed with
0.2, 0.1, 0.05, and 0.025 mM final concentrations of MnCl2. PCR
was carried out with a program of 95°C for 4 min followed by 32
cycles of 94°C for 1 min, 50°C for 1 min, and 72°C for 1 min and
finally 72°C for 7 min. The PCR products were purified using a QIA-
quick gel extraction kit (Qiagen, Valencia, CA), combined and di-
gested with the restriction enzymes XbaI and NotI. The DNA frag-
ments were ligated into the corresponding sites of the pUCmod
vector [11] and electrotransformed into competent E. coli JM109
harboring pAC-crtE-crtB-crtI14. Transformants were plated on LB
agar plates supplemented with 100 g/ml carbenicillin and 50 g/
ml chloramphenicol. After 18 hr of incubation at 30°C in the dark,
colonies were replicated using a nitrocellulose membrane and
transferred onto fresh LB plates containing the same antibiotics.
Colonies were screened visually for color variants after an addi-
tional 24 hr incubation at room temperature. Mutations in the crtOx
sequence were confirmed by DNA sequencing.
Carotenoid Production and Extraction
For HPLC and HPLC-mass spectrometry analysis, 100 ml cultures
were grown in LB medium supplemented with 0.5% glycerol, 100
g/ml carbenicillin, and 50 g/ml chloramphenicol at 30°C for 24
hr and cells harvested by centrifugation (30 min, 4000 × g, 4°C).
Carotenoid extraction was performed as described previously [12].
In brief, 5 ml of acetone was added to cell pellets and samples
incubated in a sonicating water bath at 4°C for 30 min, followed
by centrifugation (20 min, 4000 × g, 4°C) to remove cell debris.
1Extractions with acetone were repeated until no visible pigment
remained and the supernatants pooled. Pooled extracts were dried
down completely under a stream of N2 gas and resuspended in 5
ml of ethyl acetate. Carotenoids were two-phase extracted with
110 ml 5 M NaCl, the solvent phase recovered, dried down, and
resuspended in hexane or ethyl acetate.
1TLC Analysis
Crude and purified C30 and C40 carotenoid extracts were initially
analyzed by thin-layer choromatography with Whatman normal
1phase silica gel 60 plates developed using hexane:ethyl acetate
(3:1).
1HPLC and HPLC-Mass Spectrometry Analysis of Carotenoids
HPLC separation was performed using a Zorbax 300SB-C18 col-
umn (4.6 × 150 mm, 2.5 m; Agilent Technologies, Palo Alto, CA) at
1a flow rate of 1 ml min−1 using an Agilent 1100 HPLC system
equipped with a photodiode array detector. For carotenoid separa-
tions the mobile phase consisted of dH2O:acetonitrile (30:70) for
0–5 min followed by a gradient to 100% acetonitrile at 45 min. Mass
1spectrometry was performed under the same conditions as HPLC
analysis. Mass spectra were monitored in a mass range of m/z 200–
1000 on a LCQ mass spectrophotometer equipped with an atmo-
1sphere pressure chemical ionization (APCI) interface (Thermo Finni-
gan, USA) as described previously [12].
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